• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Blogs » BioWorld Perspectives » A Modest Proposal to the IgNobel Committee

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

A Modest Proposal to the IgNobel Committee

Sep. 26, 2012
By Anette Breindl

I always love reading about the IgNobel Prizes. The stated goal of the prize is to reward research that “first makes people laugh, and then makes them think.” And this year’s crop of winners once again succeeds at those tasks.

Take the 2012 Neuroscience IgNobel. It went to a team of scientists “for demonstrating that brain researchers, by using complicated instruments and simple statistics, can see meaningful brain activity anywhere.”

The winning study illustrated that using modern measurement methods, which can collect massive amounts of data, without updating statistical methods accordingly will almost inevitably lead to false positives. In their study, the winning team demonstrated statistically significant brain activity in fMRI measurements of an Atlantic salmon that was asked to judge people’s emotional state from a series of photographs. A dead Atlantic Salmon.

The work has deep implications for how to do statistical analyses of brain imaging studies. But it is hysterically funny on its surface. Personally, it also reminded me of an episode during graduate school when I walked into my institute’s neural prosthesis research lab to find some of my fellow graduate students busily inserting a cochlear implant into a watermelon.

They did then put said watermelon (which was standing in for a patient head due to its similar size and water content) into our fMRI scanner, but only to see how the scanner and implant affected each other. In retrospect, of course, they should have played the watermelon some tones while they were at it to see whether it could categorize them. Who knew?

Looking at this year’s prizes, though, I think another group of neuroscientists was robbed. The recent paper demonstrating that decision-making in drugged monkeys can be improved through a cortical prosthesis , titled “Facilitation and restoration of cognitive function in primate prefrontal cortex by a neuroprosthesis that utilizes minicolumn-specific neural firing” is surely worth some sort of prize.

Engineering, Biology and Neuroscience are all possibilities for which category of IgNobel this work merits. But I would personally favor the IgNobel Peace Prize.

There are certainly plenty of drug users that could do with some improved decision-making, for the benefit of all of society. But why stop there? The possibilities if this were to be routinely implanted in political officeholders boggle the mind.

And just imagine if the prosthetics team started collaborating with this year’s Neuroscience winners! Or with my erstwhile colleagues at the Leibniz Institute! “Facilitation and restoration of cognitive function in the post-mortem Atlantic Salmon / in the common watermelon Citrullus lanatis by a neuroprosthesis that uses minicolumn-specific neural firing” ‑ I would write a story about that for sure.

Unless, of course, the statistics were fishy.

Editor’s note: What’s your favorite IgNobel? Cast your vote here: www.bioworld.com (See the poll at the bottom right corner).

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe